Literatur
Meyer A, Buhl R, Magnussen H (1994) The effect of oral N-acetylcystein on lung glutathione levels in idiopathic pulmonary fibrosis. Eur Respir J 7:431–436
Meyer A, Buhl R, Kampf S, Magnussen H (1995) Intravenous N-acetylcystein and lung glutathione of patients with pulmonary fibrosis and normals. Am J Respir Crit Care Med 152:1055–1060
Raghu G, Johnson WC, Lockhard D, Mageto Y (1999) Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfemidone: results of a prospective, openlabel Phase II study. Am J Respir Crit Care Med 159:1061–1069
Raghu G, Brown K, Bradford WZ et al. (2004) A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 350:125–133
Ziesche R, Hofbauer E, Wittmann K et al. (1999) A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 341:1264–1269 (Erratum, N Engl J Med 2000; 342:524).
Interessenkonflikt:
Keine Angaben
Author information
Authors and Affiliations
Additional information
Folgender Originalbeitrag wurde für Sie gelesen und kommentiert:
Demedts M et al. (2005) High-dose acetylcysteine in idiopathic pulmonary fibrosis. NEJM 353:2229–2242
Rights and permissions
About this article
Cite this article
Kirsten, D. Azetylzystein bei idiopathischer Lungenfibrose. Pneumologe 3, 145–148 (2006). https://doi.org/10.1007/s10405-006-0085-0
Issue Date:
DOI: https://doi.org/10.1007/s10405-006-0085-0